Stockreport

Why Is Monte Rosa Therapeutics Stock Surging On Monday? [Yahoo! Finance]

Monte Rosa Therapeutics, Inc.  (GLUE) 
PDF commercialization license agreement with Novartis AG (NYSE: NVS ) to advance VAV1 MGDs, including MRT-6160 MRT-6160 is currently in an ongoing Phase 1, single ascendin [Read more]